What are the COVID-19 guidelines for surveillance of head and neck mucosal melanomas?

Updated: May 07, 2020
  • Author: Neeraj N Mathur, MBBS, MS, DNB(ENT), MNAMS, FAMS; Chief Editor: Arlen D Meyers, MD, MBA  more...
  • Print


Appropriate surveillance intensity

The intensity of patient surveillance should be guided by the patient’s recurrence risk and balanced against risks to patients, health-care workers, and the community.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!